Surgical and oncological outcomes after ultrasound-guided robotic liver resections for malignant tumor. Analysis of a prospective database
Related Experiment Video
Updated: Jan 25, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
Benedetta Pesi1, Luca Moraldi1, Francesco Guerra1
1Division of Oncological and Robotic General Surgery, Careggi University Hospital, Florence, Italy.
Aim:
Robotic surgery is thought to have a role in widening the application of minimally invasive liver surgery. Nonetheless, data concerning surgical results for liver malignancies are presently still lacking. We aimed to evaluate the surgical and oncological outcomes of ultrasound guided robotic liver resections for hepatic malignancies.
Methods:
All consecutive patients who received robotic resection of primary and secondary liver malignancies from September 2008 to January 2017 were analyzed. The same surgical team performed all procedures following the principle of parenchymal-sparing surgery.
Results:
From a total of 51 patients, 13 patients (25%) underwent major and 38 (75%) minor hepatectomy. No mortality occurred. Two procedures were converted to open surgery. Five patients experienced major complications, with a reintervention rate of 6%. Median hospital stay was 5 days.
Conclusions:
Robotic surgery is a safe and feasible procedure for liver resection even when dealing with malignancies. Our data show that robotic surgery can be considered a valid option to treat patients with liver malignancies in a minimally invasive manner, without compromise the oncological results.
Insights
Robotic liver resection is safe and effective for treating liver malignancies. This minimally invasive approach offers valid oncological outcomes without compromising patient safety.
Area of Science:
- Hepatobiliary Surgery
- Minimally Invasive Surgery
- Surgical Oncology
Background:
- Minimally invasive liver surgery is expanding, but data on robotic approaches for liver malignancies are limited.
- Robotic surgery may enhance the application of minimally invasive techniques in liver surgery.
Purpose of the Study:
- To evaluate the surgical and oncological outcomes of ultrasound-guided robotic liver resections for hepatic malignancies.
Main Methods:
- Retrospective analysis of 51 consecutive patients undergoing robotic liver resection for primary and secondary malignancies (September 2008 - January 2017).
- All procedures performed by a single surgical team using parenchymal-sparing techniques.
Main Results:
- 51 patients (13 major, 38 minor hepatectomies) had no mortality.
- Two conversions to open surgery; 5 patients (9.8%) experienced major complications with a 6% reintervention rate.
- Median hospital stay was 5 days.
Conclusions:
- Robotic liver resection is a safe and feasible option for managing liver malignancies.
- It enables minimally invasive treatment without compromising oncological results.
- Robotic surgery represents a valid alternative for liver cancer treatment.
More Related Videos
Related Concept Videos
Predicting Reaction Outcomes
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

